NCT01055795 2012-12-24
BEL
Duke University
Phase 1 Completed
Clinical Trials
3 trialsNCT01148628 2011-09-13
Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors
Southern Europe New Drug Organization
Phase 1 Unknown
NCT01226056 2010-10-21
Sorafenib in Combination With RAD001 in Advanced Solid Tumors Selected on Molecular Targets
Southern Europe New Drug Organization
Phase 1/2 Suspended